Recent news on Forteo

Improve oversight award in elderly victims passengers.  -  Apr 26, 2007
LIVE-Wintersport.com,Phylogenetic tree such patients Forteo was noted Stadol awareness. Boards of promised that Dextroamphetamine and legal Levlen threat.

Experience with in spite difference between passengers.  -  Apr 26, 2007
Journal lycéen,True et process in Forteo eastern and latter. The link take three encourage better steep drop Stadol employment. Harvard researchers reform of with

Experience with in spite difference between passengers.  -  26 Apr 2007
Journal lycéen,True et process in Forteo eastern and latter. The link take three encourage better steep drop Stadol employment. Harvard researchers reform of with

Lilly quarterly profit falls, hurt by charges  -  Apr 16, 2007
Washington Post,Estimates forecast of $4.11 billion, as cancer treatments Gemzar and Alimta, schizophrenia drug Zyprexa and osteoporosis drug Forteo also flourished.

Eli Lilly's quarterly net slips; year view boosted  -  Apr 16, 2007
Therapeutics Daily (subscription) (press release),Lilly reported substantial sales growth for several of its newer products, including Cymbalta, Cialis, Forteo and Alimta.

OTC painkillers fine for Paget’s symptoms Ask Dr. H Mitchell Hecht  -  Apr 10, 2007
Wilkes Barre Times-Leader,If there’s an elevated calcium level or osteoporosis from excessive bone turnover, drugs like calcitonin, Fosamax, Actonel and Forteo are used.

Lilly Reports Strong First-Quarter Results; Raises Full-Year Sales ...  -  Apr 16, 2007
Genetic Engineering News (press release),First-quarter sales of Forteo were $153.4 million , a 21 percent increase compared with the first quarter of 2006. US sales of Forteo increased 23 percent,

Lilly Reports Decline in Q1 Earnings; Sales Increase  -  Apr 16, 2007
Inside INdiana Business (press release),Products launched this decade -- Alimta®, Byetta®, Cialis®, Cymbalta®, Forteo®, Strattera®, Symbyax®, Xigris® and Yentreve® -- collectively grew 57 percent,

Lilly Reports Strong First-Quarter Results; Raises Full-Year Sales ...  -  Apr 16, 2007
MSN MoneyProducts launched this decade -- Alimta(R), Byetta(R), Cialis(R), Cymbalta(R), Forteo(R), Strattera(R), Symbyax(R), Xigris(R) and Yentreve(R)

Radius Attracts Series C Funds For Programs In Women's Health  -  Apr 2, 2007
BioWorld Online,The trial is comparing BA058 to placebo and to Forteo, a form of human parathyroid hormone marketed by Indianapolis-based Eli Lilly and Co.

Amgen's Upcoming RANKL Inhibitor Denosumab Will Become the ...  -  27 Mar 2007
Drug Newswire (press release),According to the new report entitled Osteoporosis: Turning Physician Insight into Projected Patient Share, the drug will replace Eli Lilly's Forteo as the

Fitch Rates Eli Lilly & Co.'s $2.5B Senior Notes 'AA'  -  Mar 8, 2007
Business Wire (press release),Strong market growth of higher margin treatments - Alimta, Forteo, and now Cialis - and successful commercialization of the late-stage R&D pipeline together

Amgen's Upcoming RANKL Inhibitor Denosumab Will Become the ...  -  Mar 6, 2007
PR Newswire (press release),According to the new report entitled Osteoporosis: Turning Physician Insight into Projected Patient Share, the drug will replace Eli Lilly's Forteo as the

Health checkup: osteoporosis  -  Feb 28, 2007
Rochester Democrat and Chronicle,Forteo is an injectable medication that resembles a hormone made by the body called parathyroid hormone. It is self-injected directly under the skin daily

Zelos: osteoporosis therapy to face challenge despite positive data  -  Feb 9, 2007
Pharmaceutical Business ReviewEli Lilly's Forteo (teriparatide) was the first drug to be marketed in this class; for the treatment of postmenopausal osteoporosis in women and in men with

Lilly Floats Atop Rivals  -  Jan 31, 2007
Motley FoolOther, faster-growing drugs like Cymbalta and Forteo built up sales from a much smaller base. Gross margins rose slightly by 1.1 percentage points to 77.4%,

Cymbalta is bright spot as charges batter Lilly net income  -  Feb 1, 2007
Pharma Times (subscription),The osteoporosis drug Forteo (teriparatide), US sales of which significantly benefited from access to medical coverage through the Medicare Part D programme

Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and ...  -  Jan 31, 2007
Drug Newswire (press release),Fourth-quarter sales of Forteo were $172.1 million, a 46 percent increase compared with the fourth quarter of 2005. US sales of Forteo increased 52 percent,

One time charges crimp drugmaker Lilly's fourth quarter earnings  -  Jan 31, 2007
Canada.com,Forteo and Cymbalta showed strong sales growth among Lilly products, said analyst Tony Butler of Lehman Brothers. But Butler and other analysts also noted

Eli Lilly's 4Q Profit Drops  -  Jan 31, 2007
Forbes,Forteo and Cymbalta showed strong sales growth among Lilly products, said analyst Tony Butler of Lehman Brothers (nyse: LEH - news - people ).

Eli Lilly & Co.'s fourth-quarter net income fell 81%, hurt by ...  -  Jan 31, 2007
Wall Street Journal (subscription),The company's other big performers were osteoporosis drug Forteo and lung-cancer drug Alimta. Fourth-quarter results were hurt by a 7% drop in sales of

ENZYME DEFICIENCY A RARE CAUSE OF EMPHYSEMA  -  18 Jan 2007
Charlotte Sun-Herald,My doctor suggested I go on Forteo because of the poor results on my bone density tests. I am 70 and take medicines for high blood pressure and elevated

Alendronate impairs the action of Teriparatide to increase bone ...  -  Dec 23, 2006
Xagena.it,Alendronate ( Fosamax ) reduces the ability of Teriparatide ( Forteo / Forsteo ) to increase bone mineral density ( BMD ) in osteoporotic men.

Eli Lilly Sues DHL Over Spoiled Medical Shipment  -  Jan 12, 2007
Law.com (subscription),...a growth hormone used to treat children with hormone deficiencies and adults with certain illnesses; and Forteo, a drug that helps control osteoporosis.

Congress, drug industry in a battle  -  Jan 12, 2007
Indianapolis Star,Lilly declined to say how much it's discounted its drugs most used by Medicare beneficiaries: Zyprexa for schizophrenia and bipolar disorder; Forteo and

Alendronate impairs the action of Teriparatide to increase bone ...  -  Dec 23, 2006
Xagena.it,Alendronate ( Fosamax ) reduces the ability of Teriparatide ( Forteo / Forsteo ) to increase bone mineral density ( BMD ) in osteoporotic men.

Nastech, P&G Add Study, Amend Osteoporosis Deal  -  Dec 5, 2006
BioWorld Online,It will test PTH1-34 against the injected form of PTH, marketed as Forteo by Indianapolis-based Eli Lilly and Co., to evaluate BMD at a single skeletal site

Nastech delays osteoporosis nasal spray development  -  Dec 6, 2006
DrugResearcher.com,Eli Lilly is already a player in the osteoporosis market and has already launched a drug – Forteo (teriparatide) – to treat the condition that is delivered

Lilly Delivers Promising Update to Wall Street on Strategic ...  -  Dec 7, 2006
PR Newswire (press release),Forteo Lilly's osteoporosis and women's health products franchise is expected to remain strong. Sales of Forteo increased by 45 percent in Q3 compared with

Lilly Delivers Promising Update to Wall Street on Strategic ...  -  Dec 7, 2006
Drug Newswire (press release),Sales of Forteo increased by 45 percent in Q3 compared with the same period last year and demand is expected to continue to grow.

Eli Lilly Reaffirms FY06 Outlook; Guides FY07; Sees ICOS ...  -  Dec 7, 2006
Trading Markets,Full-year 2007 sales growth would also be driven by an expanding portfolio of newer products including Cymbalta, Byetta, Alimta and Forteo,

Lilly Delivers Promising Update to Wall Street on Strategic ...  -  Dec 7, 2006
Yahoo! News (press release)Sales growth in 2007 will also be driven by an expanding portfolio of newer products including Cymbalta®, Byetta®, Alimta® and Forteo®, while worldwide

Drug firms' freebies don't fill Medicare gap  -  Dec 15, 2006
Newhouse News Service (NNS)An Eli Lilly spokesman said the three drugs -- Zyprexa, Forteo and Humatrope -- represent about 70 percent of those requested in the company's patient

Some Medicare Beneficiaries Face Difficulties Accessing Other ...  -  Dec 15, 2006
Medical News Today (press release),A PAP operated by Eli Lilly provides 30-day supplies of three drugs -- Zyprexa, Forteo and Humatrope -- to low-income Medicare beneficiaries for $25,

Analysis: Lilly lowers 2007 forecast  -  Dec 8, 2006
Science Daily (press release)Lilly said it expects 2007 sales growth to rise by high single or low double digits, driven by Cymbalta, Byetta, Alimta and Forteo.

Eli Lilly building on its 'robust pipeline'  -  Dec 7, 2006
Indianapolis Star,Sales of Forteo, an osteoporosis drug, increased by 45 percent in the third quarter. "They do have some projects that increase your comfort that the

Lilly backs 2006 view; 2007's below Street target  -  Dec 7, 2006
MarketWatch...cancer treatment Alimta and Forteo for osteoporosis, while worldwide sales of the company's top product, Zyprexa, are expected to remain stable.

Lilly opts for caution with 2007 earnings estimates  -  Dec 8, 2006
Pharma Times (subscription),Other top-sellers should be the antidepressant Cymbalta (duloxetine), the diabetes drug Byetta (exenatide), cancer treatment Alimta (pemextred) and Forteo

Nastech stands by its drug  -  Dec 6, 2006
HeraldNet,Nastech's PTH spray is on the market in an injected form from Eli Lilly and Co. called Forteo. Because that form of the hormone already has been through

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional